Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-18

Clinical Trial Update: Impact of Breakfast Composition on Glycemic and Incretin Responses in Individuals With Type 2 Diabetes [NA]

View source ↗

Summary

A completed clinical trial studied how breakfast composition affects glycemic and incretin responses in individuals with type 2 diabetes, with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Missouri-Columbia | Conditions: Type 2 Diabetes | NA | Status: COMPLETED | Results posted: 2017-01-18